Healthcare-focused venture capital (VC) firm HealthQuad, which recently cashed out profitably from the Asian Institute of Nephrology and Urology, is positive about exit opportunities in India despite macro market headwinds.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
